Vericel earnings were $16.5M for the trailing 12 months ending Dec 31, 2025, with 57.1% growth year over year. The latest VCEL earnings report on Dec 31, 2025 announced Q4 2025 earnings of $23.2M, up 358.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VCEL reported annual earnings of $16.5M, with 59.4% growth.
VCEL past earnings growth
How has VCEL's earnings growth performed historically?
On VCEL's earnings call on Invalid Date, Vericel (NASDAQ: VCEL) reported Q4 2025 earnings per share (EPS) of $0.46, up 15% year over year. Total VCEL earnings for the quarter were $23.24 million. In the same quarter last year, Vericel's earnings per share (EPS) was $0.40.
As of the last Vericel earnings report, Vericel is currently profitable. Vericel's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $16.52 million, a 59.41% increase year over year.
What was VCEL's earnings growth in the past year?
As of Vericel's earnings date in Invalid Date, Vericel's earnings has grown 57.14% year over year. This is 25.56 percentage points lower than the US Biotechnology industry earnings growth rate of 82.71%. VCEL earnings in the past year totalled $16.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.